Authors:
KIRCHENGAST S
HARTMANN B
SCHWEPPE KW
HUSSLEIN P
Citation: S. Kirchengast et al., IMPACT OF MATERNAL BODY BUILD CHARACTERISTICS ON NEWBORN SIZE IN 2 DIFFERENT EUROPEAN POPULATIONS, Human biology, 70(4), 1998, pp. 761-774
Citation: Kw. Schweppe, USE OF GNRH AGONISTS IN EXTENSIVE AND REC URRENT ENDOMETRIOSIS, Archives of gynecology and obstetrics, 260(1-4), 1997, pp. 225-226
Authors:
KIESEL L
SCHWEPPE KW
SILLEM M
SIEBZEHNRUBL E
Citation: L. Kiesel et al., SHOULD ADD-BACK THERAPY FOR ENDOMETRIOSIS BE DEFERRED FOR OPTIMAL RESULTS, British journal of obstetrics and gynaecology, 103, 1996, pp. 15-17
Authors:
WALTER M
BERG H
LEIDENBERGER FA
SCHWEPPE KW
NORTHEMANN W
Citation: M. Walter et al., AUTOREACTIVE EPITOPES WITHIN THE HUMAN ALPHA-ENOLASE AND THEIR RECOGNITION BY SERA FROM PATIENTS WITH ENDOMETRIOSIS, Journal of autoimmunity, 8(6), 1995, pp. 931-945
Citation: Kw. Schweppe, EFFECT OF GNRH-ANALOG TREATMENT WITH A DE POT-PREPARATION IN PATIENTSWITH ENDOMETRIOSIS, Die medizinische Welt, 45(5), 1994, pp. 183-188
Authors:
SCHINDLER AE
BUHLER K
METTLER L
FUCHS U
CIRKEL U
OCHS H
SCHWEPPE KW
KOCH R
Citation: Ae. Schindler et al., TREATMENT OF ENDOMETRIOSIS WITH THE GNRH AGONIST BUSERELIN (SUPRECUR(R)) - A MULTICENTRIC STUDY, Geburtshilfe und Frauenheilkunde, 54(10), 1994, pp. 569-573